Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort

Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort

We sought to characterize thyroid dysfunction and its association with baseline clinical and demographic characteristics, as well as progression-free survival (PFS), in a multiethnic cohort of lung cancer patients treated with ICIs. A retrospective chart review of lung cancer patients receiving an a...

Full description

Bibliographic Details
Main Authors: Angelica D’Aiello, Juan Lin, Rasim Gucalp, Vafa Tabatabaie, Haiying Cheng, Noah A. Bloomgarden, Yaron Tomer, Balazs Halmos
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
immune-related adverse events
checkpoint inhibitors
immunotherapy
thyroid
NSCLC
SCLC
Online Access:https://www.mdpi.com/2072-6694/13/6/1464

Internet

https://www.mdpi.com/2072-6694/13/6/1464

Similar Items